<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28916" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Serotonin</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bamalan</surname>
            <given-names>Omar A.</given-names>
          </name>
          <aff>Imam Abdulrahman Bin Faisal University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moore</surname>
            <given-names>Marlyn J.</given-names>
          </name>
          <aff>Uniformed Services University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Al Khalili</surname>
            <given-names>Yasir</given-names>
          </name>
          <aff>Virginia Commonwealth University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Omar Bamalan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marlyn Moore declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yasir Al Khalili declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28916.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Serotonin, or 5-hydroxytryptamine (5-HT), is a neurotransmitter with an integral physiological role in the human body; it regulates various activities, including behavior, mood, memory, and gastrointestinal homeostasis.<xref ref-type="bibr" rid="article-28916.r1">[1]</xref><xref ref-type="bibr" rid="article-28916.r2">[2]</xref>&#x000a0;Serotonin is synthesized in the raphe nuclei of the brainstem and the enterochromaffin cells of the intestinal mucosa.<xref ref-type="bibr" rid="article-28916.r3">[3]</xref><xref ref-type="bibr" rid="article-28916.r4">[4]</xref></p>
        <p>Serotonin&#x000a0;is a primary treatment target for many psychiatric and neurological disorders associated with decreased CNS and plasma serotonin&#x000a0;concentration, such as major depressive disorder, post-traumatic stress disorder, obsessive-compulsive disorder, and anxiety disorders.<xref ref-type="bibr" rid="article-28916.r5">[5]</xref><xref ref-type="bibr" rid="article-28916.r6">[6]</xref>&#x000a0;</p>
        <p>Other neurotransmitters (such as norepinephrine and dopamine) are also targets of treatment for the pathologies mentioned above; however, therapies that affect serotonin&#x000a0;are often considered first-line in pharmacologic management in addition to other interventions such as lifestyle changes, physical exercise, and psychotherapy.<xref ref-type="bibr" rid="article-28916.r7">[7]</xref><xref ref-type="bibr" rid="article-28916.r8">[8]</xref></p>
      </sec>
      <sec id="article-28916.s2" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>The synthesis of serotonin (5-HT) begins with the essential amino acid tryptophan, which undergoes hydroxylation (an oxidation reaction) to 5-hydroxy-L-tryptophan (5-HTP) and decarboxylation to 5-hydroxytryptamine (5-HT). The hydroxylation reaction requires tryptophan hydroxylase, which is considered the rate-limiting enzyme of serotonin production, and the decarboxylation reaction requires aromatic-L-amino acid decarboxylase. Tryptophan hydroxylase is primarily localized to the raphe nuclei of the brain and enterochromaffin cells of the intestinal mucosa, the main sites of serotonin production.<xref ref-type="bibr" rid="article-28916.r9">[9]</xref>&#x000a0;</p>
        <p>Enzymatic cofactors for the two reactions necessary for serotonin synthesis are tetrahydrobiopterin (BH4) and pyridoxine (vitamin B6), respectively. Tryptophan hydroxylase is dependent on the cofactor tetrahydrobiopterin, the recycling of which relies on folic acid (vitamin B9) metabolism.<xref ref-type="bibr" rid="article-28916.r10">[10]</xref> Aromatic-L-amino acid decarboxylase is dependent upon the coenzyme pyridoxal 5&#x02032;-phosphate (PLP), a form of pyridoxine. Therefore, serotonin production is metabolically dependent on BH4 and vitamin B6.<xref ref-type="bibr" rid="article-28916.r11">[11]</xref> Of note, serotonin is a precursor to melatonin, a pivotal sleep regulator.<xref ref-type="bibr" rid="article-28916.r12">[12]</xref></p>
        <p>Serotonin activity is regulated by its rate of synthesis, release, and metabolism. The majority of serotonin is intracellular, allowing for relatively tight control of its concentration. Serotonin is stored in intracellular vesicles, enters the synaptic cleft after neuron depolarization, then binds to G-protein coupled receptors (GPCRs) on either the presynaptic or postsynaptic membrane.<xref ref-type="bibr" rid="article-28916.r9">[9]</xref></p>
        <p>Presynaptic receptors are auto-regulators that inhibit further serotonin release. Postsynaptic receptors propagate either an excitatory or inhibitory pathway via second messenger cascades, depending on which receptor subtype is involved.<xref ref-type="bibr" rid="article-28916.r13">[13]</xref> Serotonin that is recycled back to the cell via serotonin transporter (SERT) is then either stored in vesicles or metabolized by monoamine oxidase (MAO) in the cytoplasm.&#x000a0;Peripheral serotonin is metabolized by the liver and lungs.<xref ref-type="bibr" rid="article-28916.r9">[9]</xref></p>
      </sec>
      <sec id="article-28916.s3" sec-type="Function">
        <title>Function</title>
        <p>Aside from serotonin&#x02019;s role as a neurotransmitter in the CNS, it has several other functions.</p>
        <list list-type="bullet">
          <list-item>
            <p>Central nervous system: Serotonin is widely known for its effect on mood, but it also plays a role in memory, anger, fear, appetite, stress, addiction, sexual pleasure, sleep, pain perception, cerebral vascular tone, and central respiratory drive.<xref ref-type="bibr" rid="article-28916.r1">[1]</xref></p>
          </list-item>
          <list-item>
            <p>Ocular: Serotonin can activate ciliary body muscle fibers and cause pupil dilation leading to increased intraocular pressure.<xref ref-type="bibr" rid="article-28916.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Cardiovascular: Serotonin has positive inotropic and chronotropic effects by increasing intracellular calcium in cardiac myocytes, which can trigger tachyarrhythmias.<xref ref-type="bibr" rid="article-28916.r15">[15]</xref> Serotonin can be stored in platelet granules and plays a role in platelet aggregation. Serotonin can contribute to vasodilation, in the setting of intact endothelium and vasoconstriction, in the setting of damaged endothelium.<xref ref-type="bibr" rid="article-28916.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>Pulmonary: Serotonin affects the central respiratory drive, increases pulmonary vascular resistance, and may induce remodeling of the pulmonary vasculature.<xref ref-type="bibr" rid="article-28916.r1">[1]</xref></p>
          </list-item>
          <list-item>
            <p>Gastrointestinal: Serotonin increases gastric emptying, gut motility, intestinal secretion, and colonic tone.<xref ref-type="bibr" rid="article-28916.r1">[1]</xref><xref ref-type="bibr" rid="article-28916.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>Endocrine/Metabolic: Serotonin regulates pancreatic secretion, increases insulin secretion, glucose uptake in muscle tissue, lipogenesis in fat tissue, and lipid accumulation in the liver.<xref ref-type="bibr" rid="article-28916.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>Genitourinary: Serotonin modulates micturition, uterine vasoconstriction, uterine muscle tone, oocyte maturation, and penile detumescence.<xref ref-type="bibr" rid="article-28916.r1">[1]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28916.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Excessive serotonin activity can cause several pathologic symptoms.</p>
        <p>
<bold>Neuromuscular</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tremor</p>
          </list-item>
          <list-item>
            <p>Hyperreflexia</p>
          </list-item>
          <list-item>
            <p>Myoclonus</p>
          </list-item>
          <list-item>
            <p>Hypertonia</p>
          </list-item>
        </list>
        <p>
<bold>Autonomic</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Mydriasis</p>
          </list-item>
          <list-item>
            <p>Diaphoresis</p>
          </list-item>
          <list-item>
            <p>Tachycardia</p>
          </list-item>
          <list-item>
            <p>Tachypnea</p>
          </list-item>
          <list-item>
            <p>Hyperthermia</p>
          </list-item>
          <list-item>
            <p>Vomiting</p>
          </list-item>
          <list-item>
            <p>Arrhythmias</p>
          </list-item>
        </list>
        <p>
<bold>Neurological</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Agitation</p>
          </list-item>
          <list-item>
            <p>Excitement</p>
          </list-item>
          <list-item>
            <p>Insomnia</p>
          </list-item>
          <list-item>
            <p>Confusion</p>
          </list-item>
          <list-item>
            <p>Anxiety</p>
          </list-item>
        </list>
        <p>Serotonin syndrome (SS) or serotonin toxicity (ST) is a condition and potential adverse event due to excessive serotonin stimulation on CNS and visceral organs due to aberrant serotonin accumulation. Often, this is due to an accidental or intentional overdose of one or more serotonin-elevating medications. The spectrum of clinical manifestations can be life-threatening; thus, recognizing the manageable signs and symptoms that appear first is crucial to preventing deterioration.</p>
        <p>The signs and symptoms may develop 24 hours after medication ingestion, and diagnosis depends on a thorough history, medication reconciliation, and physical exam. Key features of serotonin syndrome include&#x000a0;a patient history of taking a serotonergic agent, generalized clonus that is both spontaneous and inducible, ocular clonus, tremor, hyperreflexia, hyperthermia, diaphoresis, hyperactive bowels, and agitation or delirium.<xref ref-type="bibr" rid="article-28916.r18">[18]</xref></p>
        <p>Alternatively, upon the abrupt dose reduction or discontinuation of serotonergic medications, patients may be at risk for SSRI discontinuation syndrome. Symptoms have been described as &#x0201c;flu-like&#x0201d; and may arise within a few days of medication cessation and persist for up to two weeks. One mnemonic for the symptoms is FINISH: flu-like symptoms, insomnia, nausea, imbalance, sensory disturbances, and hyperarousal.<xref ref-type="bibr" rid="article-28916.r19">[19]</xref></p>
        <p>Carcinoid syndrome is a paraneoplastic syndrome with some clinical overlap with serotonin syndrome. Carcinoid syndrome is due to aberrant serotonin production from a neuroendocrine neoplasm. Symptoms include flushing (from serotonin&#x02019;s vasoactive function) and diarrhea (from serotonin&#x02019;s role in gastrointestinal motility).<xref ref-type="bibr" rid="article-28916.r20">[20]</xref></p>
      </sec>
      <sec id="article-28916.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Decreased or ineffective serotonin activity is thought to be central to the pathogenesis of depression, anxiety, and other psychologic disorders. As such, treatments to increase serotonin concentration within the synapse or maximize serotonin receptors' potentiality are often considered the first line to improve patients' clinical symptoms.<xref ref-type="bibr" rid="article-28916.r1">[1]</xref><xref ref-type="bibr" rid="article-28916.r21">[21]</xref></p>
        <p>There are several classes of medications that target the serotonergic system:</p>
        <p>
<bold>Selective Serotonin Reuptake Inhibitors (SSRI)</bold>
</p>
        <p>These are the first line of medications in moderate to severe anxiety disorders and depressive disorders; they can also be used in other neuropsychiatric disorders (eg, eating disorders, obsessive and compulsive disorders) as adjunctive therapies. The mechanism of action involves blocking 5-HT down-regulating presynaptic reuptake channels, thereby increasing synaptic 5-HT concentration.<xref ref-type="bibr" rid="article-28916.r22">[22]</xref>&#x000a0;</p>
        <p>Side effects may include headache, agitation or mild irritability, sleepiness, nausea or constipation, dizziness, and sexual dysfunction (eg, delayed ejaculation, anorgasmia). In patients with bipolar disorder, SSRIs may trigger mania. SSRIs also carry a black box warning for increased suicidality in teens and young adults; however, it is unclear if this corresponds to legitimate suicide attempts versus suicidal ideation.<xref ref-type="bibr" rid="article-28916.r23">[23]</xref>&#x000a0;Examples of SSRIs include fluoxetine, citalopram, escitalopram, paroxetine, sertraline, and fluvoxamine.</p>
        <p>
<bold>Serotonin Norepinephrine Reuptake Inhibitors (SNRI)</bold>
</p>
        <p>These are also the first line of medications and function similarly to SSRIs with a similar side effect profile but may be more "stimulating." In addition to inhibiting 5-HT reuptake, these mediations also inhibit norepinephrine reuptake. Examples of SNRIs are venlafaxine, desvenlafaxine, and duloxetine.</p>
        <p>
<bold>Monoaminoxidase Inhibitors (MAOI) (eg, phenelzine, selegiline)</bold>
</p>
        <p>MAOIs are often used in depressive and anxiety disorders that fail to respond to SSRIs and SNRIs. The mechanism of action is either reversible or irreversible antagonism of monoaminoxidase, one of the enzymes that degrade serotonin. Decreased degradation of neurotransmitters results in prolonged time within the synaptic cleft for these neurotransmitters to propagate their downstream effects.&#x000a0;The side effects include sweating, tremors, sedation, postural hypotension, and atropine-like effects such as blurry vision, dry mouth, and urinary retention. Patients are advised to avoid food and drink high in tyramine (some cheeses, wine, pickles, and other fermented foods) while taking MAOIs due to the risk of increased norepinephrine release leading to hypertensive crisis.<xref ref-type="bibr" rid="article-28916.r24">[24]</xref>&#x000a0;Examples of MAOIs are phenelzine, selegiline, isocarboxazid, and tranylcypromine.</p>
        <p>
<bold>Tricyclic Anti-depressants (TCA)</bold>
</p>
        <p>TCAs inhibit the presynaptic serotonin and norepinephrine reuptake channels and the post-synaptic histamine, cholinergic, and alpha-adrenergic receptors. As a result, side effects include sedation, weight gain, anticholinergic effects, and tachycardia.<xref ref-type="bibr" rid="article-28916.r25">[25]</xref><xref ref-type="bibr" rid="article-28916.r26">[26]</xref>&#x000a0;Examples of TCAs include&#x000a0;amitriptyline, nortriptyline, imipramine, desipramine, clomipramine, doxepin, and amoxapine.</p>
        <p>
<bold>5-HT Receptor Agonist/Partial Agonists</bold>
</p>
        <p>Serotonin receptor agonists are most commonly used in the treatment of migraines. 5-HT receptor agonists lead to&#x000a0;cerebral vasoconstriction, reduced trigeminal nerve activation, reduced nociception, and inhibition of the pro-inflammatory CGRP cascade. Potential side effects include coronary vasoconstriction because the serotonin receptor subtypes responsible for cerebral vasoconstriction are also located in cardiac tissue.<xref ref-type="bibr" rid="article-28916.r27">[27]</xref>&#x000a0;Examples include zolmitriptan, rizatriptan, and sumatriptan.</p>
      </sec>
      <sec id="article-28916.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28916&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28916">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28916/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28916">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-28916.s7">
        <fig id="article-28916.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Metabolic pathway from tryptophan to serotonin. Image is licensed under the Creative Commons Attribution-Share Alike 3.0 Unported license. Author: RicHard-59 based on Trp-5ht-pathway.png by Likeitsmyjob. Downloaded from https://commons.wikimedia.org/wiki/File:Trp-5ht-pathway.svg</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="serotonin" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-28916.s8">
        <title>References</title>
        <ref id="article-28916.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>The expanded biology of serotonin.</article-title>
            <source>Annu Rev Med</source>
            <year>2009</year>
            <volume>60</volume>
            <fpage>355</fpage>
            <page-range>355-66</page-range>
            <pub-id pub-id-type="pmid">19630576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Layunta</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Latorre</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grasa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Arruebo</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Buey</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alcalde</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Mesonero</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Intestinal serotonergic system is modulated by Toll-like receptor 9.</article-title>
            <source>J Physiol Biochem</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>689</fpage>
            <page-range>689-701</page-range>
            <pub-id pub-id-type="pmid">35670957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hornung</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>The human raphe nuclei and the serotonergic system.</article-title>
            <source>J Chem Neuroanat</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>331</fpage>
            <page-range>331-43</page-range>
            <pub-id pub-id-type="pmid">14729135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raghupathi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Duffield</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Zelkas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Meedeniya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brookes</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sia</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Wattchow</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Keating</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Identification of unique release kinetics of serotonin from guinea-pig and human enterochromaffin cells.</article-title>
            <source>J Physiol</source>
            <year>2013</year>
            <month>Dec</month>
            <day>01</day>
            <volume>591</volume>
            <issue>23</issue>
            <fpage>5959</fpage>
            <page-range>5959-75</page-range>
            <pub-id pub-id-type="pmid">24099799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masand</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Selective serotonin-reuptake inhibitors: an update.</article-title>
            <source>Harv Rev Psychiatry</source>
            <year>1999</year>
            <season>Jul-Aug</season>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>69</fpage>
            <page-range>69-84</page-range>
            <pub-id pub-id-type="pmid">10471245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Owens</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Nemeroff</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.</article-title>
            <source>Clin Chem</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>288</fpage>
            <page-range>288-95</page-range>
            <pub-id pub-id-type="pmid">7508830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Micheli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ceccarelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'Andrea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tirone</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Depression and adult neurogenesis: Positive effects of the antidepressant fluoxetine and of physical exercise.</article-title>
            <source>Brain Res Bull</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>143</volume>
            <fpage>181</fpage>
            <page-range>181-193</page-range>
            <pub-id pub-id-type="pmid">30236533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strawn</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Geracioti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rajdev</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Clemenza</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.</article-title>
            <source>Expert Opin Pharmacother</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>19</volume>
            <issue>10</issue>
            <fpage>1057</fpage>
            <page-range>1057-1070</page-range>
            <pub-id pub-id-type="pmid">30056792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohammad-Zadeh</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Moses</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gwaltney-Brant</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Serotonin: a review.</article-title>
            <source>J Vet Pharmacol Ther</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>187</fpage>
            <page-range>187-99</page-range>
            <pub-id pub-id-type="pmid">18471139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fanet</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Capuron</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Castanon</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Calon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vancassel</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry.</article-title>
            <source>Curr Neuropharmacol</source>
            <year>2021</year>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>591</fpage>
            <page-range>591-609</page-range>
            <pub-id pub-id-type="pmid">32744952</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cellini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zelante</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dindo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bellet</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Renga</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Romani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Costantini</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Pyridoxal 5'-Phosphate-Dependent Enzymes at the Crossroads of Host-Microbe Tryptophan Metabolism.</article-title>
            <source>Int J Mol Sci</source>
            <year>2020</year>
            <month>Aug</month>
            <day>13</day>
            <volume>21</volume>
            <issue>16</issue>
            <pub-id pub-id-type="pmid">32823705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Hille</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Serotonin modulates melatonin synthesis as an autocrine neurotransmitter in the pineal gland.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2021</year>
            <month>Oct</month>
            <day>26</day>
            <volume>118</volume>
            <issue>43</issue>
            <pub-id pub-id-type="pmid">34675083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Hougaard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Knudsen</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Ashina</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Serotonergic mechanisms in the migraine brain - a systematic review.</article-title>
            <source>Cephalalgia</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>251</fpage>
            <page-range>251-264</page-range>
            <pub-id pub-id-type="pmid">27013238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>McIntyre</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Weng</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study.</article-title>
            <source>PLoS One</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>e0173005</fpage>
            <pub-id pub-id-type="pmid">28257449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neumann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hofmann</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dhein</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gergs</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease.</article-title>
            <source>Int J Mol Sci</source>
            <year>2023</year>
            <month>Mar</month>
            <day>01</day>
            <volume>24</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">36902195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Halperin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reber</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Influence of antidepressants on hemostasis.</article-title>
            <source>Dialogues Clin Neurosci</source>
            <year>2007</year>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-59</page-range>
            <pub-id pub-id-type="pmid">17506225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yabut</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Crane</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Keating</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>WI</given-names>
              </name>
              <name>
                <surname>Steinberg</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule.</article-title>
            <source>Endocr Rev</source>
            <year>2019</year>
            <month>Aug</month>
            <day>01</day>
            <volume>40</volume>
            <issue>4</issue>
            <fpage>1092</fpage>
            <page-range>1092-1107</page-range>
            <pub-id pub-id-type="pmid">30901029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scotton</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions.</article-title>
            <source>Int J Tryptophan Res</source>
            <year>2019</year>
            <volume>12</volume>
            <fpage>1178646919873925</fpage>
            <pub-id pub-id-type="pmid">31523132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gabriel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Antidepressant discontinuation syndrome.</article-title>
            <source>CMAJ</source>
            <year>2017</year>
            <month>May</month>
            <day>29</day>
            <volume>189</volume>
            <issue>21</issue>
            <fpage>E747</fpage>
            <pub-id pub-id-type="pmid">28554948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gade</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Olariu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Douthit</surname>
                <given-names>NT</given-names>
              </name>
            </person-group>
            <article-title>Carcinoid Syndrome: A Review.</article-title>
            <source>Cureus</source>
            <year>2020</year>
            <month>Mar</month>
            <day>05</day>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>e7186</fpage>
            <pub-id pub-id-type="pmid">32257725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salomon</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Cowan</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Oscillatory serotonin function in depression.</article-title>
            <source>Synapse</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>67</volume>
            <issue>11</issue>
            <fpage>801</fpage>
            <page-range>801-20</page-range>
            <pub-id pub-id-type="pmid">23592367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edinoff</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Akuly</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Hanna</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Ochoa</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Patti</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Ghaffar</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Kaye</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Viswanath</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Urits</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Boyer</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Cornett</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Kaye</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review.</article-title>
            <source>Neurol Int</source>
            <year>2021</year>
            <month>Aug</month>
            <day>05</day>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>387</fpage>
            <page-range>387-401</page-range>
            <pub-id pub-id-type="pmid">34449705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>WO</given-names>
              </name>
              <name>
                <surname>Callahan</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Shintani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fuchs</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Shelton</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Dudley</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Graves</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Antidepressants and suicide attempts in children.</article-title>
            <source>Pediatrics</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>133</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-10</page-range>
            <pub-id pub-id-type="pmid">24394688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edinoff</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Swinford</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Odisho</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Burroughs</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Raslan</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Cornett</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Kaye</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Kaye</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors.</article-title>
            <source>Health Psychol Res</source>
            <year>2022</year>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>39576</fpage>
            <pub-id pub-id-type="pmid">36425231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gillman</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Tricyclic antidepressant pharmacology and therapeutic drug interactions updated.</article-title>
            <source>Br J Pharmacol</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>151</volume>
            <issue>6</issue>
            <fpage>737</fpage>
            <page-range>737-48</page-range>
            <pub-id pub-id-type="pmid">17471183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feighner</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Mechanism of action of antidepressant medications.</article-title>
            <source>J Clin Psychiatry</source>
            <year>1999</year>
            <volume>60 Suppl 4</volume>
            <fpage>4</fpage>
            <page-range>4-11; discussion 12-3</page-range>
            <pub-id pub-id-type="pmid">10086478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28916.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rubio-Beltr&#x000e1;n</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Labastida-Ram&#x000ed;rez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Villal&#x000f3;n</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>MaassenVanDenBrink</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Is selective 5-HT<sub>1F</sub> receptor agonism an entity apart from that of the triptans in antimigraine therapy?</article-title>
            <source>Pharmacol Ther</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>186</volume>
            <fpage>88</fpage>
            <page-range>88-97</page-range>
            <pub-id pub-id-type="pmid">29352859</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
